Anthony M. Joshua, Malaka Ameratunga, Aura Serrano, Angelina Lay, Robert Kent, Trifon Psaroulis, Antonia Reale, Mandeep Singh Kalsi, Cris Laplap, Rasha Cosman, Mark J. Shackleton. "SILVER (supplementing tebentafusp with subcutaneous IL-2 to verifiably eradicate radiological progression): A phase 1/2 trial of IL-2 with tebentafusp upon first radiological progression on first-line tebentafusp alone.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps9606